OP Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.8M Buy
48,667
+19,389
+66% +$7.19M 0.2% 82
2026
Q1
$8.57M Sell
29,278
-5,096
-15% -$1.67M 0.09% 162
2025
Q4
$12M Buy
34,374
+170
+0.5% +$57.4K 0.14% 117
2025
Q3
$11.1M Sell
34,204
-27,162
-44% -$8.45M 0.14% 119
2025
Q2
$23.9M Buy
61,366
+12,783
+26% +$5.14M 0.34% 45
2025
Q1
$21.1M Buy
+48,583
New +$19.5M 0.35% 45

Other funds holding ELV

OP Asset Management's ELV Position: Q2 2026 in Review

OP Asset Management increased its Elevance Health (ELV) stake by 66% in Q2 2026, buying an estimated $7.19M and bringing the position to 48,667 shares worth $18.8M. The position accounts for 0.2% of the portfolio, ranked #82.

OP Asset Management first reported a position in ELV in Q1 2025 and has held it in 6 quarters since. The position peaked at $23.9M in Q2 2025. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • OP Asset Management held 48,667 shares of Elevance Health worth $18.8M as of Q2 2026.
  • OP Asset Management bought 19,389 Elevance Health shares in Q2 2026, an estimated $7.19M.
  • Elevance Health made up 0.2% of OP Asset Management's portfolio in Q2 2026, its #82 holding.
  • OP Asset Management first reported a position in Elevance Health in Q1 2025 and has held it in 6 quarters since.
  • OP Asset Management's Elevance Health position peaked at $23.9M in Q2 2025.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.